Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovation campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Deerfield Announces $15 Million Investment in Wellfount

NEW YORK– (BUSINESS WIRE)–Deerfield Management Company announced today that it has entered into an agreement to provide Wellfount Corporation with $15.0 million in funding. With these amounts, Wellfount will possess sufficient working capital to continue to expand the portfolio of long term care facilities in which its innovative pharmacy solution is implemented. Wellfount currently provides medications to over 3,000 residents in eight states, using a safe, cost effective approach that combines technologically sophisticated remote dispensing units with high touch, on-site customer service.

Under the terms of the agreement, Deerfield funded the entire $15 million upon closing. Interest on the balance accrues at 10.75% per annum and must be repaid within five years. Deerfield also received warrants to purchase shares of Series B Preferred Stock in the company.

“We believe that Wellfount’s unique approach to the delivery of long term care pharmacy services enables the company to improve service levels, enhance patient safety and reduce costs in a very differentiated way,” commented Leslie Henshaw, Partner at Deerfield Management. “Our objective with this funding is to strengthen Wellfount’s financial position with flexible, minimally dilutive capital that will allow it to meet growing client demand for implementing its solution in new facilities.”

“Wellfount has recently doubled its business and added a national footprint,”said Eric Orme, CEO and President of Wellfount. “The Deerfield team demonstrated a very broad understanding of both the market and our specific needs during this high growth period. They worked closely with us to create a financing platform that allows us to execute as we enter new geographic markets. We have found the right partner in Deerfield to help manage both the short and long term success of Wellfount.”

About Wellfount Corp.

Wellfount is a pioneering institutional pharmacy providing pharmaceutical products and services to both local and national long-term care facilities that house an increasing number of the nation’s aging population. The company aims to address the shortcomings of traditional LTC pharmacy services through its innovative TED Rx pharmacy service. Wellfount’s TED Rx system enables on-demand patient-specific medication dispensing at the point of care, which reduces drug waste and helps eliminate human error. Wellfount is headquartered in Indianapolis, IN.

About Deerfield Management Company

Deerfield is an investment management firm, committed to advancing healthcare through investment, information and philanthropy. For more information about Deerfield,please visit www.deerfield.com

Contacts

Deerfield Management Company
Karen Heidelberger, 212-692-7140
[email protected]